A new type of sustainability index is at access-to-medicine.org. Well named by Innovest, it's an index that attempts to measure access to medicine. The key indicators for performance are listed below. (...from their site, where they also list a non-profit heavy -- not pharmaceutical-heavy -- list of stakeholders):
The key indicators for performance are:
20% Access to Medicines Management 20% Research & Development into Neglected Diseases 18% Equitable Pricing 15% Patents & Licensing 10% Policy Influence & Lobbying 7% Drug Donations 5% Philanthropic Activities 5% Ethical Promotion & Marketing Activities
Comments